title: Association of serum adiponectin and insulin-like growth factor I levels with parameters of cardiac remodeling in severely obese patients.
abstract: BACKGROUND
  Obesity is associated with various changes in cardiac geometry and this process involves both hemodynamic and non-hemodynamic factors, among which adipocitokines and growth factors may play an important role. The aim of this study was to identify the extent and pattern of cardiac remodeling in a group of severely obese patients and analyze the relationship between adiponectin, IGFI and cardiac parameters reflecting obesity-associated structural changes.
  
  
  METHODS
  Our study included 344 patients (104 men) with severe obesity [mean body mass index (BMI)= 45.7 ± 8.5 kg/m(2)], extensively evaluated clinically and biologically (complete metabolic tests, serum adiponectin, and IGF-I measurements). Left ventricular (LV) mass index (LVMI), left atrium (LA) size, and LV geometry were determined by means of cardiac ultrasound.
  
  
  RESULTS
  The most prevalent pattern of LV geometry was eccentric hypertrophy (28.7% of patients). In a gender-, age-, BMI-, diabetes- and hypertension-adjusted general linear model, patients with concentric or eccentric hypertrophy had significantly lower values of adiponectin than those with normal geometry (6.75 ± 0.41, 6.96 ± 0.53, vs 9.04 ± 0.42 mg/l, p<0.05). In multivariate analysis, independent determinants for LVMI were BMI (β=0.364, p<0.001), systolic blood pressure (BP) (β=0.187, p=0.004), age (β=0.246, p<0.001), adiponectin (β=-0.151, p=0.012), and IGF-I z-score (β=0.134, p=0.025) while factors independently related to LA size were systolic BP (β=0.218, p<0.001), BMI (β=0.194, p<0.001), age (β=0.273, p<0.001), gender (β=-0.195, p<0.001), and adiponectin (β=-0.180, p=0.005).
  
  
  CONCLUSIONS
  In patients with severe obesity, IGF-I z score and adiponectin correlate with parameters of cardiac remodeling independently of anthropometric, hemodynamic or metabolic factors.
authors.affiliation: Carol Davila University of Medicine and Pharmacy, Endocrinology Department, Elias University Hospital, Bd Marasti, 17, sector 1, Bucharest, Romania.
authors.forename: A
authors.initials: A
authors.lastname: Sirbu
authors.forename: I
authors.initials: I
authors.lastname: Stanca
authors.forename: C
authors.initials: C
authors.lastname: Copaescu
authors.forename: S
authors.initials: S
authors.lastname: Martin
authors.forename: A
authors.initials: A
authors.lastname: Albu
authors.forename: C
authors.initials: C
authors.lastname: Barbu
authors.forename: S
authors.initials: S
authors.lastname: Fica
mesh_terms: D052242:Adiponectin / Q000097:blood*; D000328:Adult; D005260:Female; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000097:blood* / Q000000981:diagnostic imaging; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000097:blood* / Q000503:physiopathology; D014463:Ultrasonography; D020257:Ventricular Remodeling / Q000502:physiology*
chemical_list: D052242:Adiponectin; D007334:Insulin-Like Growth Factor I
references.citation: J Clin Endocrinol Metab. 2008 Jul;93(7):2811-8
references.pmid: 18397982
references.citation: Endocr Rev. 2004 Feb;25(1):102-52
references.pmid: 14769829
references.citation: Physiol Rev. 2008 Apr;88(2):389-419
references.pmid: 18391168
references.citation: Circulation. 1999 Oct 26;100(17):1802-7
references.pmid: 10534468
references.citation: Hypertens Res. 2008 May;31(5):825-31
references.pmid: 18712036
references.citation: J Am Coll Cardiol. 1992 Jun;19(7):1550-8
references.pmid: 1534335
references.citation: Endocr J. 2008 Jul;55(3):523-8
references.pmid: 18469485
references.citation: J Am Coll Cardiol. 2004 Apr 21;43(8):1399-404
references.pmid: 15093874
references.citation: Am J Cardiol. 1986 Feb 15;57(6):450-8
references.pmid: 2936235
references.citation: Heart Lung Circ. 2008 Feb;17(1):19-24
references.pmid: 17560167
references.citation: Nat Clin Pract Cardiovasc Med. 2007 Aug;4(8):436-43
references.pmid: 17653116
references.citation: J Int Med Res. 2007 Nov-Dec;35(6):909-16
references.pmid: 18084850
references.citation: Can J Cardiol. 1996 Mar;12(3):264-70
references.pmid: 8624976
references.citation: J Clin Endocrinol Metab. 2002 Jul;87(7):3097-104
references.pmid: 12107207
references.citation: Diabetes Care. 2006 Jun;29(6):1357-62
references.pmid: 16732021
references.citation: Hypertension. 2002 Mar 1;39(3):739-43
references.pmid: 11897755
references.citation: Nature. 2006 Dec 14;444(7121):875-80
references.pmid: 17167476
references.citation: Circulation. 1993 May;87(5):1715-21
references.pmid: 7683979
references.citation: J Biol Chem. 2004 Jul 30;279(31):32771-9
references.pmid: 15159410
references.citation: Circulation. 1994 Feb;89(2):799-809
references.pmid: 8313569
references.citation: J Hypertens. 2007 Feb;25(2):471-7
references.pmid: 17211256
references.citation: Exp Clin Endocrinol Diabetes. 2012 Mar;120(3):171-4
references.pmid: 22402920
references.citation: N Engl J Med. 1999 Oct 7;341(15):1097-105
references.pmid: 10511607
references.citation: Circulation. 2004 Nov 9;110(19):3081-7
references.pmid: 15520317
references.citation: Obes Surg. 2009 Sep;19(9):1324-32
references.pmid: 19629601
references.citation: J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
references.pmid: 16376782
references.citation: Eur Heart J. 2008 Sep;29(18):2227-33
references.pmid: 18611964
references.citation: Am J Cardiol. 1997 Sep 15;80(6):736-40
references.pmid: 9315579
references.citation: Circulation. 2001 Mar 13;103(10):1453-8
references.pmid: 11245652
references.citation: J Biol Chem. 2004 Jul 2;279(27):28670-4
references.pmid: 15123726
references.citation: JAMA. 2004 Nov 24;292(20):2471-7
references.pmid: 15562125
references.citation: Am Heart J. 1995 Aug;130(2):306-13
references.pmid: 7631612
references.citation: Herz. 2006 Jun;31(4):305-16
references.pmid: 16810470
references.citation: Hypertension. 2007 Jun;49(6):1448-54
references.pmid: 17420337
references.citation: Circ Res. 2007 Aug 17;101(4):335-47
references.pmid: 17702980
references.citation: Blood Press. 2004;13(4):236-42
references.pmid: 15581338
references.citation: J Endocrinol Invest. 2006;29(3 Suppl):77-82
references.pmid: 16751711
references.citation: J Am Coll Cardiol. 2007 Feb 6;49(5):531-8
references.pmid: 17276175
references.citation: J Anim Sci. 2005 Mar;83(3):565-78
references.pmid: 15705753
references.citation: J Clin Endocrinol Metab. 2007 Feb;92(2):571-6
references.pmid: 17119002
references.citation: J Mol Cell Cardiol. 2007 Jun;42(6):1065-74
references.pmid: 17499764
references.citation: Clin Chem Lab Med. 2004;42(6):654-64
references.pmid: 15259383
references.citation: JAMA. 2001 May 16;285(19):2486-97
references.pmid: 11368702
references.citation: N Engl J Med. 2002 Aug 1;347(5):305-13
references.pmid: 12151467
references.citation: J Hypertens. 2010 Apr;28(4):856-64
references.pmid: 20042874
references.citation: Ann Intern Med. 1983 Dec;99(6):757-61
references.pmid: 6651022
references.citation: Am J Cardiol. 2004 Jun 15;93(12):1569-72
references.pmid: 15194042
references.citation: Cardiovasc Res. 1995 Dec;30(6):825-34
references.pmid: 8746194
references.citation: Am J Hypertens. 2005 Feb;18(2 Pt 1):191-6
references.pmid: 15752946
references.citation: Hypertension. 2007 Jan;49(1):34-9
references.pmid: 17130310